| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
|
|
|
|
|||||||||||||
|
|
|||||||||||||||
Leader |
1 Department of Immunology, Imperial College School of Medicine, St Mary's Campus, London W2 1PG, UK
Professor Bangham email: c.bangham{at}ic.ac.uk Human T lymphotropic virus type 1 (HTLV-1) causes disabling and fatal diseases, yet there is no vaccine, no satisfactory treatment, and no means of assessing the risk of disease or prognosis in infected people. Recent research on the molecular virology and immunology of HTLV-1 shows the importance of the host's immune response in reducing the risk of these diseases, and is beginning to explain why some HTLV-1 infected people develop serious illnesses whereas most remain healthy life long carriers of the virus. These findings might be applicable to other persistent virus infections such as human immunodeficiency virus, hepatitis B, and hepatitis C.
Key Words: human T lymphotropic virus type 1 • adult T cell leukaemia/lymphoma • tropical spastic paraparesis • myelopathy
This article has been cited by other articles:
|
|
 |
|
  M. S. Mitchell, E. T. Bodine, S. Hill, G. Princler, P. Lloyd, H. Mitsuya, M. Matsuoka, and D. Derse Phenotypic and Genotypic Comparisons of Human T-Cell Leukemia Virus Type 1 Reverse Transcriptases from Infected T-Cell Lines and Patient Samples J. Virol., May 1, 2007; 81(9): 4422 - 4428. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Agnellini, P. Wolint, M. Rehr, J. Cahenzli, U. Karrer, and A. Oxenius Impaired NFAT nuclear translocation results in split exhaustion of virus-specific CD8+ T cell functions during chronic viral infection PNAS, March 13, 2007; 104(11): 4565 - 4570. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Plancoulaine, A. Gessain, P. Tortevoye, A. Boland-Auge, A. Vasilescu, F. Matsuda, and L. Abel A major susceptibility locus for HTLV-1 infection in childhood maps to chromosome 6q27 Hum. Mol. Genet., November 15, 2006; 15(22): 3306 - 3312. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Mitra-Kaushik, J. Harding, J. Hess, R. Schreiber, and L. Ratner Enhanced tumorigenesis in HTLV-1 Tax-transgenic mice deficient in interferon-gamma Blood, November 15, 2004; 104(10): 3305 - 3311. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Mitra-Kaushik, J. C. Harding, J. L. Hess, and L. Ratner Effects of the proteasome inhibitor PS-341 on tumor growth in HTLV-1 Tax transgenic mice and Tax tumor transplants Blood, August 1, 2004; 104(3): 802 - 809. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. D. Dodon, Z. Li, S. Hamaia, and L. Gazzolo Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells J. Gen. Virol., July 1, 2004; 85(7): 1921 - 1932. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H.-K. Chung, H. A. Young, P. K. C. Goon, G. Heidecker, G. L. Princler, O. Shimozato, G. P. Taylor, C. R. M. Bangham, and D. Derse Activation of interleukin-13 expression in T cells from HTLV-1-infected individuals and in chronically infected cell lines Blood, December 1, 2003; 102(12): 4130 - 4136. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Ding, S.-J. Kim, A. M. Nair, B. Michael, K. Boris-Lawrie, A. Tripp, G. Feuer, and M. D. Lairmore Human T-Cell Lymphotropic Virus Type 1 p12I Enhances Interleukin-2 Production during T-Cell Activation J. Virol., October 15, 2003; 77(20): 11027 - 11039. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J J Z. Imirizaldu, J C G. Esteban, I R. Axpe, T P. Concha, F V. Juanes, I A. Susaeta, and J M C. Carranceja Post-transplantation HTLV-1 myelopathy in three recipients from a single donor J. Neurol. Neurosurg. Psychiatry, August 1, 2003; 74(8): 1080 - 1084. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Ding, B. Albrecht, R. E. Kelley, N. Muthusamy, S.-J. Kim, R. A. Altschuld, and M. D. Lairmore Human T-Cell Lymphotropic Virus Type 1 p12I Expression Increases Cytoplasmic Calcium To Enhance the Activation of Nuclear Factor of Activated T Cells J. Virol., September 11, 2002; 76(20): 10374 - 10382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Albrecht and M. D. Lairmore Critical Role of Human T-Lymphotropic Virus Type 1 Accessory Proteins in Viral Replication and Pathogenesis Microbiol. Mol. Biol. Rev., September 1, 2002; 66(3): 396 - 406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Debacq, B. Asquith, P. Kerkhofs, D. Portetelle, A. Burny, R. Kettmann, and L. Willems Increased cell proliferation, but not reduced cell death, induces lymphocytosis in bovine leukemia virus-infected sheep PNAS, July 23, 2002; 99(15): 10048 - 10053. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
B. Albrecht, C. D. D'Souza, W. Ding, S. Tridandapani, K. M. Coggeshall, and M. D. Lairmore Activation of Nuclear Factor of Activated T Cells by Human T-Lymphotropic Virus Type 1 Accessory Protein p12I J. Virol., March 7, 2002; 76(7): 3493 - 3501. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lomas, E. Hanon, Y. Tanaka, C. R. M. Bangham, and K. G. Gould Presentation of a new H-2Dk-restricted epitope in the Tax protein of human T-lymphotropic virus type I is enhanced by the proteasome inhibitor lactacystin J. Gen. Virol., March 1, 2002; 83(3): 641 - 650. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS | REGISTER |
| Journal of Clinical Pathology | Molecular Pathology |
